Maverix Provides Analytic Support To Rare Genomics Institute Competition
Complete the form below to unlock access to ALL audio articles.
Maverix Biomics, Inc. will provide $50,000 in analytic support to the Rare Genomics Institute (RGI) competition, BeHEARD (Helping Empower and Accelerate Research Discoveries), an annual rare disease science challenge. Bioinformatics support for the contest will be conducted on the Maverix Analytic Platform, a cloud-based solution that leverages proven open-source algorithms and applications developed at leading academic and research centers.
The RGI-hosted contest is aimed at accelerating personalized rare disease research and offering new options for patients suffering from hard-to-diagnose and treat ailments. The competition is open globally to researchers, foundations, or anyone whose idea is constrained due to limited resources. Research proposals will be evaluated by an expert panel of scientists, and prizes for the challenge include access to sponsored cutting-edge technology and services. Interested researchers can apply here: http://beheard2015.raregenomics.org/home
“Maverix is pleased to be integrally involved in a program where our genomic analysis technology will further accelerate the understanding of a specific rare disease,” said Dave Mandelkern, Maverix CEO. “Bioinformatics is the key to advancing scientific discovery in rare disease research.”
One or more winning research proposals in the BeHEARD challenge will have the opportunity to choose between two of Maverix’s most popular analysis kits, the DNA-seq Exome variant analysis kit, or the mRNA-seq expression analysis kit. In addition to providing up to 100 analysis kits on the Maverix Analytic Platform, three months of free data storage will also be included.
